Journal: Current medical research and opinion

Article Title: Vascular effects of the lercanidipine/enalapril combination: clinical relevance.

PMID/MRN: 27779459

Publication Date: 2016-Oct-26

Abstract:

Hypertension is associated with alterations in the vascular structure, which in turn enhance the risk of cardiovascular events. Notably, anti-hypertensive treatment may prevent or regress the changes of arterial wall structures. Lercanidipine is a third-generation CCB with peculiar pharmaceutical properties. Enalapril is an effective drug acting on the renin-angiotensin-aldosterone axis. This commentary discusses the vascular effects of the lercanidipine/enalapril combination, and comments on their potential clinical relevance.